Fundraising FoxEos Advisory — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Carcinotech produces bioprinted tumor models combining patient-derived biological material with automated workflows to generate reproducible tumor tissue systems for drug discovery and testing.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesEdinburgh, GB
Lorna(Chief Scientific Officer)
Co-investorsAlba EquityTRICAPITALBritish Business BankGabriel Investment SyndicateInvesting Women AngelsInvestment Fund for Scotland+4 more
The Concinnity Company provides a cloud-based process management and automation platform designed to reduce delays and improve efficiency in clinical trials.
Cloud ComputingDigital HealthEnterprise SoftwareHealthtechMedical DevicesSaaSNashville, US
Heidi Solomon Allen(Secretary)inMichael Alan Lalor(Chief Financial Officer)Nancy Falls(Chief Executive Officer)in
Co-investorsMaven Capital PartnersOld College CapitalScottish Enterprise
Cumulus Oncology is a drug development company specializing in oncology therapeutics, leveraging experienced leadership with track records in new drug applications and successful M&A transactions.
BiotechHealthtechLongevityMedical Devices
Catherine(CEO)Clare Wareing(CEO)in
Co-investorsAlba EquityApollo Informal InvestmentScottish National Investment BankScottish Enterprise
Nami Surgical is a company developing surgical technology and seeks investors and partners across clinical, commercial, and technological domains.
HealthtechMedical DevicesRoboticsGlasgow, GB
Nico Fenu(Co-Founder & Chief Operating Officer)inNICOLA GIUSEPPE FENU(Executive Officer, Director)Rebecca Cleary(Co-Founder & Chief Technical Officer)inNikki Palfrey(Chief Executive Officer)inALBERT NICHOLL(Director)in
Co-investorsMaven Capital PartnersScottish Enterprise
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.